Download Induction of auto-reactive regulatory T cells by stimulation with

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Induction of auto-reactive regulatory T cells by
stimulation with immature autologous dendritic cells.
Jin Y, Fuller L, Esquenazi V, Blomberg BB, Burke GW, Ciancio G, Tzakis
AG, Ricordi C, Miller J.
The Lillian Jean Kaplan Renal Transplant Center of the Division of
Transplantation of the Department of Surgery, University of Miami, Leonard M.
Miller School of Medicine, Miami, Florida 33101, USA. [email protected]
We have shown in ex vivo studies in donor bone marrow-infused kidney
transplant recipients, that chimeric cells of either donor or recipient origin taken
from the recipient's bone marrow down-regulated the recipient's cellular immune
responses. In the present study, we have now induced regulatory T cells from
peripheral blood mononuclear cells (PBMC) of renal transplant recipients or
laboratory volunteers by multi-stimulation with autologous immature dendritic
cell (iDC) enriched populations derived from either bone marrow cells (BMC) of
the (immunosuppressed) kidney transplant recipients or PBMC of the laboratory
volunteers (i.e., ibDC and ipDC, respectively). These regulatory T cells, induced
by ibDC and ipDC, were autoreactive and designated as TAb and TAp with
similar phenotypes and functional profiles. They were largely CD4 + CD25high,
CD45RA low and CD45RO high, and uniformly expressed intracellular CTLA-4,
and message of IL-4, IL-10, Foxp3, and differentially expressed TGFbeta. Their
proliferative responses to autologous mature dendritic stimulating cells (mDC)
were approximately two-fold stronger than to allogeneic mDC, and to allogeneic
mDC were significantly lower than those of (control) autologous TPBL,
suggesting an anergic state. TAb and TAp were not cytotoxic to autologous cells
expressing Epstein-Barr virus (EBV) antigens, but were able to inhibit (regulate)
the effector phase of this TPBL response to both autologous and allogeneic EBV
lymphoblasts. This regulation appeared to require cell-to-cell contact.